Sa-001 (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 298 | Hereditary pancreatitis | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00401076 (ClinicalTrials.gov) | July 2008 | 16/11/2006 | A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency | A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy | Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy | Drug: SA-001 | Abbott | NULL | Completed | 20 Years | N/A | Both | 80 | Phase 3 | Japan |
| 2 | NCT00400842 (ClinicalTrials.gov) | May 2007 | 16/11/2006 | A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency | A Double-blind, Placebo-controlled, Parallel-group, Comparative Study to Confirm the Safety and Efficacy of Oral 1.5 g/Day and 3.0 g/Day of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy | Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Drug: SA-001;Drug: Placebo | Abbott | NULL | Completed | 20 Years | N/A | Both | 274 | Phase 3 | Japan |